Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 131 for “"Celecoxib"”.
-
[alpha]-TEA & celecoxib in skin cancer prevention & therapy
The cyclooxygenase-2 (COX-2) specific inhibitor celecoxib reduces tumor incidence in skin cancer and progression of skin tumors, but the benefits of celecoxib are lost with cessation of treatment. The absence of lasting effects highlights the need for an effective combination treatment. In this …
-
Sildenafil and celecoxib interact to kill breast cancer cells
… a phosphodiesterase type 5 inhibitor, and celecoxib, a cyclooxygenase-2 inhibitor, have been used individually in conjunction with other chemotherapeutic agents to enhance cell killing in a variety of cancers. Sildenafil when combined with traditional chemotherapeutic drugs, such as the …
-
The effects of celecoxib on skeletal muscle in rodents
Celecoxib is a non-steroidal anti-inflammatory drug (NSAID) that inhibits the cyclooxygenase (COX) 2 enzyme, preventing the synthesis of prostaglandins and thereby playing a role in skeletal muscle adaptation to exercise. Previous studies have found that COX-2 selective NSAIDs impair muscle protein …
-
Enabling Direct Compression Tablet Development Of Celecoxib Through Solid State Engineering
… high dose non-steroidal anti-inflammatory drug, celecoxib (CEL) due to the undesirable properties of the commercial solid form of CEL, including low bulk density, poor flowability and tablet lamination issues. The solid form used in commercially available CEL capsules is a polymorph of CEL, Form …
-
Effect of Perioperative Celecoxib on Patient Outcomes After Major Plastic Surgery Procedures
… to examine the hypothesis that administration of celecoxib preoperatively or postoperatively and for a total of 4 days after major plastic surgery would improve pain control and clinically-important patient outcomes. Another objective of the study was to determine if perioperative administration …
-
Celecoxib enhances sorafenib/sildenafil lethality in cancer cells and reverts platinum chemotherapy resistance
… could be enhanced by the anti-inflammatory agent celecoxib, using ovarian cancer and other tumor cell lines as models. Also, in a dose dependent fashion celecoxib enhanced [sorafenib + sildenafil] lethality in multiple ovarian cancer cell lines. In a dose dependent fashion celecoxib enhanced the …
-
Einflüsse der Therapie mit Risperidon und Celecoxib auf das zelluläre Immunsystem schizophrener Patienten
Einflüsse der Therapie mit Risperidon und Celecoxib auf das zelluläre Immunsystem schizophrener Patienten
-
Effect of Short-Term Postoperative Celecoxib Administration on Patient Outcome After Outpatient Laparoscopic Surgery
… of short-term postoperative administration of celecoxib on pain management and recovery outcomes following laparoscopic surgery. Methods: Eighty consenting ASA I–III outpatients undergoing laparoscopic surgery were randomly assigned to one of two treatment groups: Control (placebo) or Celecoxib …
-
In vitro Untersuchungen zum Einfluss des selektiven COX-2 Inhibitors Celecoxib auf humane Osteoblasten
… Charité und DRFZ, 10117 Berlin, Deutschland Celecoxib ist ein wichtiger Vertreter selektiver COX-2-Inhibitoren. Dabei handelt es sich um eine potente antiinflammatorische und analgetische Substanz, die zur Behandlung von Erkrankungen des Bewegungsapparates, wie der rheumatoiden Arthritis oder …
-
THE APPLICATION OF MACROPHAGE-TARGETED, ANTI-INFLAMMATORY CELECOXIB NANOEMULGEL FOR NERVE REGENERATION IN PERIPHERAL NERVE INJURY
… a popular therapeutic target of NSAIDs (such as Celecoxib). Celecoxib (CXB), a non-steroidal anti-inflammatory drug (NSAID), is a selective COX-2 inhibitor and can be used as a non-opioid alternative pain treatment12-14. It belongs to the biopharmaceutical classification system (BCS) class II, …
-
The ACCeRT Study - Auckland’s Cancer Cachexia evaluating Resistance Training Study: A randomised feasibility study of EPA and Cox-2 inhibitor (Celecoxib) versus EPA, Cox-2 inhibitor (Celecoxib), Progressive Resistance Training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic participants
… a 1:2 ratio to Eicosapentaenoic acid (EPA) and celecoxib (Arm A), versus EPA, celecoxib, two sessions of supervised PRT per week, followed by 20g EAA over 3 days (Arm B). Results: Twenty participants enrolled in the study, seven in Arm A, and 13 in Arm B. The mean age at entry was 68.2 years and …
-
Enhancement of Antitumor Activities of a Selective Cyclooxygenase-2 Inhibitor, Celecoxib on the Lewis Lung Carcinoma that Express Cyclooxygenase-2
… to one of six groups: no treatment(group 1), celecoxib 25mg/kg daily per oral intake alone(group 2), celecoxib 75mg/kg daily per oral intake alone(group 3), 10 Gy irradiation alone in one fraction(group 3), 10 Gy irradiation with celecoxib 25mg/kg daily per oral intake(group 5), 10 Gy …
-
Differential Expression of RNA in the Rat Peripheral Nervous System Following Nerve Injury and Treatment with Pain-Relieving Celecoxib-Loaded Nanomedicine
… the non-steroidal anti-inflammatory, NSAID, Celecoxib, naturally accumulate at the site of injury resulting in relief of CCI behavioral hyper-sensitivity. It is not known beyond the inhibition of cyclooxygenase-2 (COX-2) activity and the reduction in prostaglandin E2 (PGE2), what gene …
-
Mechanisms of proliferation inhibition and apoptosis induced by vitamin E compounds and cyclooxygenase inhibitors in human breast cancer cells
… and COX-2 selective inhibitors (especially, celecoxib) in protection against breast cancer in vitro and in vivo, and to determine their cellular and molecular signaling mechanisms. Using an MDA-MB-435-FL-GFP human breast cancer xenograft model, a-TEA and celecoxib separately or in combination …
-
Development of an oral drug delivery platform formulation for the targeted delivery of celecoxib for the chemoprevention and treatment of colorectal cancer.
The anti-inflammatory drug celecoxib (CLX) has been shown to exert protective effects in colorectal cancer (CRC) therapy. The primary objective of this study was to develop and characterize a novel CLX multiparticulate drug delivery technology suitable for use in the treatment and prevention of CRC …
-
Analysis of Symptomatic and Biological Changes in Major Depressive Disorder Related to Co-Administered Antidepressant and Anti-Inflammatory Treatment
… augmented with either placebo or 400 mg daily celecoxib, for six weeks. After six weeks, participants could continue taking vortioxetine alone for an additional 29 weeks, for 35 total weeks of trial inclusion. The PREDDICT study is the largest RCT to investigate celecoxib augmentation of an …
-
Entscheidende Rolle reaktiver Sauerstoffspezies für die Bekämpfung von kutanen SCC-Zellen
… and AK. Non-steroidal anti-inflammatory drugs as celecoxib, indirubin derivatives or sinecatechins (Veregen, Polyphenon E, PE) represent promising candidates. Here, the efficacy and mode of action of celecoxib, three indirubin derivatives and PE were investigated in four cSCC cell lines. The …
Page 1 of 7